139 related articles for article (PubMed ID: 14533450)
1. UFT and oral leucovorin as radiation sensitizers in rectal and other gastrointestinal malignancies.
Saad ED; Hoff PM
Cancer Invest; 2003; 21(4):624-9. PubMed ID: 14533450
[TBL] [Abstract][Full Text] [Related]
2. Preoperative combined oral UFT plus leucovorin and radiation therapy for rectal cancer.
Diaz-Canton E; Pazdur R
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):58-60. PubMed ID: 9348571
[TBL] [Abstract][Full Text] [Related]
3. The role of UFT in combined-modality therapy.
Blanke CD; Teng M; Choy H
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):47-54. PubMed ID: 10550826
[TBL] [Abstract][Full Text] [Related]
4. Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin.
Rosenthal DI; Haller DG; Saltz L; Semple D; Minsky BD
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):59-62. PubMed ID: 11098496
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer.
Schiebe ME; Reese T; Wenz F; Schmidberger H; Engenhart-Cabillic R; Dunst J; Hess CF; Hoffmann W
Anticancer Drugs; 2002 Nov; 13(10):1005-9. PubMed ID: 12439334
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.
Hoff PM; Janjan N; Saad ED; Skibber J; Crane C; Lassere Y; Cleary KR; Benner S; Randolph J; Abbruzzese JL; Pazdur R
J Clin Oncol; 2000 Oct; 18(20):3529-34. PubMed ID: 11032595
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
8. A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancer.
Hoff PM; Saad ED; Janjan N; Skibber J; Pazdur R
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):56-8. PubMed ID: 11098495
[TBL] [Abstract][Full Text] [Related]
9. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
10. UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review.
Minsky BD
Int J Cancer; 2001 Feb; 96(1):1-10. PubMed ID: 11241325
[TBL] [Abstract][Full Text] [Related]
11. UFT (tegafur-uracil) in rectal cancer.
Casado E; Pfeiffer P; Feliu J; González-Barón M; Vestermark L; Jensen HA
Ann Oncol; 2008 Aug; 19(8):1371-1378. PubMed ID: 18381370
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer.
Kundel Y; Brenner B; Symon Z; Oberman B; Sadezki S; Koller M; Catane R; Pfeffer R
Anticancer Res; 2007; 27(4C):2877-80. PubMed ID: 17695464
[TBL] [Abstract][Full Text] [Related]
13. Current and future directions in adjuvant combined-modality therapy of rectal cancer.
Minsky BD
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):61-8. PubMed ID: 9348572
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer.
Byström P; Frödin JE; Berglund A; Wilking N; Glimelius B
Radiother Oncol; 2004 Feb; 70(2):171-5. PubMed ID: 15028404
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
Tedesco KL; Berlin J; Blanke CD; Teng M; Choy H; Roberts J; Beauchamp RD; Leach S; Wyman K; Tarpley J; Shyr Y; Caillouette C; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1364-70. PubMed ID: 15817338
[TBL] [Abstract][Full Text] [Related]
17. Life-threatening toxicity of oral tegafur-uracil (UFT) plus leucovorin.
Ribas A; Gallardo E; Vera R; Casado S; Vidal R; Bellmunt J
Clin Oncol (R Coll Radiol); 1997; 9(4):269-70. PubMed ID: 9315406
[TBL] [Abstract][Full Text] [Related]
18. Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients.
Damle B; Ravandi F; Kaul S; Sonnichsen D; Ferreira I; Brooks D; Stewart D; Alberts D; Pazdur R
Clin Cancer Res; 2001 Mar; 7(3):517-23. PubMed ID: 11297242
[TBL] [Abstract][Full Text] [Related]
19. The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potential.
Hoff PM
Invest New Drugs; 2000 Nov; 18(4):331-42. PubMed ID: 11081569
[TBL] [Abstract][Full Text] [Related]
20. [Complete disappearance of pulmonary metastases in a case of rectal cancer treated with oral tegafur-uracil (UFT) and leucovorin (LV)].
Takada A; Kawahara M; Kobayashi H; Takino Y; Kodama T; Sugishita T; Ohno Y; Oka T; Tsukamoto F
Gan To Kagaku Ryoho; 2012 Jun; 39(6):997-9. PubMed ID: 22705701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]